当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析

京新药业

(002020)

  

流通市值:107.73亿  总市值:128.12亿
流通股本:7.24亿   总股本:8.61亿

京新药业(002020)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润1.66亿元,每股收益0.20元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益613207.09万元,未分配利润353571.07万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产805804.98万元,负债192597.89万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入923,034,058.554,069,361,419.583,048,192,079.462,016,542,750.22
营业总成本738,160,639.573,228,447,527.922,417,770,049.291,599,932,166.01
其他经营收益
营业利润194,131,533.44862,654,942.4664,258,601.66450,138,341.44
利润总额191,374,366.42864,325,602.05664,916,102.75450,261,320.86
净利润166,150,235.51766,667,967.92581,417,539.53392,203,288.29
每股收益
其他综合收益209,371.89-91,596.05-121,128.61-336,679.07
综合收益总额166,359,607.4766,576,371.87581,296,410.92391,866,609.22
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计3,192,592,294.783,300,802,355.473,142,880,026.722,810,717,832.03
非流动资产:
非流动资产合计4,865,457,515.154,822,729,078.394,835,768,603.385,101,197,229.64
资产总计8,058,049,809.938,123,531,433.867,978,648,630.17,911,915,061.67
流动负债:
流动负债合计1,572,078,247.031,906,909,059.031,939,835,860.752,060,726,893.66
非流动负债:
非流动负债合计353,900,688.43346,354,873.09353,293,153.53355,040,836.29
负债合计1,925,978,935.462,253,263,932.122,293,129,014.282,415,767,729.95
所有者权益(或股东权益):
归属于母公司股东权益合计6,093,894,330.65,833,037,935.525,651,372,562.725,463,484,498.34
股东权益合计6,132,070,874.475,870,267,501.745,685,519,615.825,496,147,331.72
负债和股东权益合计8,058,049,809.938,123,531,433.867,978,648,630.17,911,915,061.67
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计982,794,705.183,946,293,309.772,990,689,343.981,949,788,386.33
经营活动现金流出小计800,938,239.213,164,946,236.932,375,205,530.611,556,879,962.08
经营活动产生的现金流量净额181,856,465.97781,347,072.84615,483,813.37392,908,424.25
投资活动产生的现金流量:
投资活动现金流入小计1,660,156,516.012,740,947,150.052,038,840,858.841,594,511,975.96
投资活动现金流出小计1,955,847,474.722,373,841,173.931,524,375,046.19961,922,973.01
投资活动产生的现金流量净额-295,690,958.71367,105,976.12514,465,812.65632,589,002.95
筹资活动产生的现金流量:
筹资活动现金流入小计89,042,500567,346,679.45373,136,048.92283,499,548.95
筹资活动现金流出小计86,744,654.881,483,095,603.541,354,514,420.771,191,858,989.07
筹资活动产生的现金流量净额2,297,845.12-915,748,924.09-981,378,371.85-908,359,440.12
汇率变动对现金及现金等价物的影响-10,431,386.1-7,217,125.84-2,087,506.29202,617.31
现金及现金等价物净增加额-121,968,033.72225,486,999.03146,483,747.88117,340,604.39
期末现金及现金等价物余额390,707,298.98512,631,931.73433,628,680.58404,485,537.09
补充资料:
现金及现金等价物的净增加额-225,486,999.03-117,340,604.39
最新报告期:2026-04-27
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
开源证券刘艺,余汝意0.981.101.242026-04-27
东方证券伍云飞,胡俊涛0.941.081.262026-04-24
方正证券许睿,周超泽1.011.151.342026-04-24
TOP↑